News

CareCloud's Innovative Approach to Dividends: A New Era Begins

CareCloud's Innovative Approach to Dividends: A New Era Begins

CareCloud's Exciting Dividend Strategy for Preferred Shareholders

CareCloud, Inc. (Nasdaq: CCLD, CCLDO) has announced a groundbreaking initiative aimed at rewarding its preferred shareholders. This new plan will pay double monthly dividends on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, beginning January 2026. The decision comes in response to the growing confidence in the company’s financial position, bolstered by enhanced margins and increasing recurring revenues.

Overview of the Dividend Plan

The Board of Directors at CareCloud has officially adopted the plan to address the 14 months of accumulated and unpaid dividends that have built up from November 2023 through December 2024. The company recognizes these dividends, totaling approximately $3.9 million, as a significant commitment to its shareholders.

In implementing this strategy, CareCloud plans to issue two payments each month: a regular monthly dividend alongside an additional payment aimed at catching up on the outstanding dividends. This dual-payment approach is designed to ensure that the company fulfills its obligations while maintaining financial stability.

Dividend Structure and Expectations

Under the current plan, the release of these double dividends will commence with the January 2026 payment. The record date for this dividend will be January 31, 2026, with disbursement expected in mid-February 2026. This innovative approach not only serves to reassure investors but also demonstrates CareCloud’s commitment to financial discipline.

Key Highlights of the Dividend Payment Schedule

  • Current Monthly Dividends: Payments have been fully reinstated since January 2025, continuing without interruptions.
  • No Dilution for Common Shareholders: Funding for the Series B Preferred Stock dividends will be secured through internal cash flow, protecting common shareholders from dilution.
  • Outstanding Arrears: A total of fourteen dividends unaccounted for, which amounts to $2.55 per share.
  • Catch-Up Payments: Starting in 2026, the plan includes one regular dividend and one additional catch-up payment monthly until all arrears are settled.
  • Completion Timeline: Full payment of the arrears is expected to be achieved by the conclusion of the first quarter of 2027.
  • Security Offered: The plan revolves around the established 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock.

Statements from CareCloud Leadership

Expressing gratitude towards shareholders, Stephen Snyder, Co-CEO of CareCloud, emphasized the importance of this plan in recognizing the support shown throughout a challenging period. He reaffirmed that CareCloud has now built a solid financial foundation and is committed to enhancing shareholder value.

Norman Roth, the Interim Chief Financial Officer, also underlined the company’s capabilities to maintain consistent monthly payments while wisely addressing past arrears. This new structure marks a crucial step forward for CareCloud as they balance growth objectives with their responsibilities to their investors.

Company’s Commitment to Innovation in Healthcare

CareCloud is dedicated to revolutionizing the healthcare industry through a blend of technology and innovation. The company's comprehensive suite of solutions, including revenue cycle management, practice management, electronic health records, and patient experience management, empowers over 40,000 providers to enhance both patient care and operational efficiency. This commitment not only streamlines clinical workflows but also significantly reduces administrative burdens and operating costs.

As CareCloud continues to grow, their emphasis on financial responsibility reinforces their dedication to all stakeholders, assuring a robust health to their business model while fostering an enriching environment for healthcare providers and patients alike.

Frequently Asked Questions

What is the new dividend plan announced by CareCloud?

CareCloud has announced a plan to pay double monthly dividends starting January 2026 to address unpaid dividends accumulated from November 2023 to December 2024.

When will the double dividends commence?

The double dividends are scheduled to begin with the January 2026 payment, which will be distributed in mid-February 2026.

How much are the outstanding dividends CareCloud needs to pay?

There are approximately $3.9 million in accumulated unpaid dividends, translating to around $2.55 per share for preferred shareholders.

Will common shareholders be affected by this dividend plan?

No, the plan will not dilute common shareholders as dividends will be funded through internally generated cash flow.

What are some of the services CareCloud offers?

CareCloud provides various services including revenue cycle management, practice management, electronic health records, and patient experience management, aimed at improving operational performance in healthcare.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
AZ Health Workers Step Up for Community Wellness

Updated Category News Views 4

Health Screenings: A Step Before the Hospital Sometimes it's the basics, like a plain old health screening, that can shift the tides from crisis to care. That's exactly where AZ Blue Health Choice and Zeihan ProHealth come into the picture, aiming to pin those health concerns before they spiral out of control. For your average Arizonan who finds healthcare as elusive as a...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 57

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 53

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading
Americas Cardroom Smashes Prize Pools; Bahamas Up Next

Updated Category News Views 49

Ah, poker. Where dreams are won with a flick of the wrist and a well-placed bluff. This week, it was all eyes on Americas Cardroom’s Dual Venom PKOs, and let me tell you, they didn't just meet expectations—they chewed them up and spat them out like yesterday's jam. Two Titans Crowned in Poker Showdown The action wrapped up with a jaw-dropping $6,862,500 prize pool....

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 4

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading

Top 5 Most Recently Viewed Articles

Clare Locke Advocates for Megan Thee Stallion in Defamation Case

Updated Category News Views 111

Clare Locke LLP Champions Megan Thee Stallion's Defamation Case Clare Locke LLP, a respected name in defamation law, has taken a bold step to support Megan Thee Stallion's pursuit of justice against Milagro Cooper. The firm has filed a motion for leave to present an amicus brief that specifically endorses Megan's effort to have a jury's defamation ruling reinstated. This...

Continue Reading
Bankers Signal Looming Economic Challenges Amid Uncertainty

Updated Category News Views 167

Bankers Signal Looming Economic Challenges Amid Uncertainty Interest rate fluctuations, credit quality, and tariffs are significant concerns for financial institutions. A recent survey highlights the anxiety among bankers regarding the economic climate and impending recession. Survey Highlights Economic Fears According to a survey from fintech IntraFi, which gathered...

Continue Reading
Dave Portnoy Questions Elon Musk Amid Tesla's Plummeting Stock

Updated Category News Views 162

Tesla's Stock Dilemma: Portnoy's Concerns Tesla’s stock, designated as TSLA, has recently experienced a significant decline, stirring up discussions among investors and enthusiasts alike. Dave Portnoy, the founder of Barstool Sports, has voiced his frustration regarding this situation, bringing forth some pointed questions about Elon Musk’s priorities. In a recent...

Continue Reading
Akropolis Group's Credit Rating Affirmed Amid Strategic Changes

Updated Category News Views 88

Akropolis Group’s Robust Credit Rating Amid Strategic Reassessments Renowned international credit rating agency S&P Global Ratings recently evaluated the financial outlook for Akropolis Group, a prominent player in the real estate development and management sector. This assessment took into account significant structural governance changes within the Vilniaus Prekyba...

Continue Reading
Arcutis Takes a Significant Step with ZORYVE Cream for Kids

Updated Category News Views 156

Arcutis Advances ZORYVE® Cream for Pediatric Use Arcutis Biotherapeutics, Inc. is making headlines with its recent submission of a supplemental New Drug Application (sNDA) aimed at expanding the use of ZORYVE (roflumilast) cream 0.3% to treat plaque psoriasis in children as young as 2 years old. If approved, ZORYVE would be the first topical PDE4 inhibitor specifically...

Continue Reading